Latest Press Releases Innate Pharma Announces Proposed Offering of Ordinary Shares August 13, 2026 Innate Pharma to advance Lacutamab towards phase 3 following partnership with Sobi and appoints new chief medical officer August 10, 2026 Innate Pharma enters strategic partnership with Sobi to license lacutamab in T-cell lymphoma August 10, 2026 Selected media Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
Innate Pharma to advance Lacutamab towards phase 3 following partnership with Sobi and appoints new chief medical officer August 10, 2026
Innate Pharma enters strategic partnership with Sobi to license lacutamab in T-cell lymphoma August 10, 2026
Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
